학술논문

Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis
Document Type
Article
Source
In: Journal of Hepatology. (Journal of Hepatology, February 2022, 76(2):464-469)
Subject
Language
English
ISSN
16000641
01688278